TY - JOUR
T1 - Frequent BRAF or EGFR mutations in ciliated muconodular papillary tumors of the lung
AU - Kamata, Tsugumasa
AU - Sunami, Kuniko
AU - Yoshida, Akihiko
AU - Shiraishi, Kouya
AU - Furuta, Koh
AU - Shimada, Yoko
AU - Katai, Hitoshi
AU - Watanabe, Shun Ichi
AU - Asamura, Hisao
AU - Kohno, Takashi
AU - Tsuta, Koji
N1 - Funding Information:
Supported in part by Grants-in-Aid from the Ministry of Health, Labor, and Welfare for Practical Research for Innovative Cancer Control (H26-practical-general-007 and H26-practical-general-135), by Management Expenses Grants from the Government to the National Cancer Center (23-A-18) and the National Cancer Center Research and Development Fund (26-A-13 and 24-A-1), and by a Grant-in-Aid for Scientific Research (C) (grant number: 25460446). We thank Sachiyo Mitani, Sachiko Miura, Noriko Abe, and Susumu Wakai for their technical assistance.
Publisher Copyright:
© 2015 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
PY - 2016
Y1 - 2016
N2 - Introduction: Ciliated muconodular papillary tumors (CMPTs) are recently characterized, rare peripheral nodules of the lung. These small tumors are histologically comprised of a vaguely organized mixture of nonatypical ciliated columnar cells, mucous cells, and basal cells, and consistently follow a benign clinical course. However, the histogenesis of CMPTs remains uncertain. Methods: We performed detailed genomic analyses of 10 archived CMPT cases, using next-generation sequencing and high-resolution melting analysis. Results: Mutations were identified in eight of the 10 cases (80%); four cases harbored the BRAF-V600E mutation, one case harbored the BRAF-G606R mutation, and three cases harbored deletions in exon 19 of EGFR. All of the deletions in EGFR were of the E746-T751/S752V subtype. Conclusions: The high prevalence of driver gene mutations in CMPTs supports the notion that these lesions are neoplastic rather than reactive or metaplastic.
AB - Introduction: Ciliated muconodular papillary tumors (CMPTs) are recently characterized, rare peripheral nodules of the lung. These small tumors are histologically comprised of a vaguely organized mixture of nonatypical ciliated columnar cells, mucous cells, and basal cells, and consistently follow a benign clinical course. However, the histogenesis of CMPTs remains uncertain. Methods: We performed detailed genomic analyses of 10 archived CMPT cases, using next-generation sequencing and high-resolution melting analysis. Results: Mutations were identified in eight of the 10 cases (80%); four cases harbored the BRAF-V600E mutation, one case harbored the BRAF-G606R mutation, and three cases harbored deletions in exon 19 of EGFR. All of the deletions in EGFR were of the E746-T751/S752V subtype. Conclusions: The high prevalence of driver gene mutations in CMPTs supports the notion that these lesions are neoplastic rather than reactive or metaplastic.
KW - BRAF
KW - Ciliated muconodular papillary tumors
KW - EGFR
KW - Histogenesis
KW - Next-generation sequencing
UR - http://www.scopus.com/inward/record.url?scp=84958985631&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958985631&partnerID=8YFLogxK
U2 - 10.1016/j.jtho.2015.10.021
DO - 10.1016/j.jtho.2015.10.021
M3 - Article
C2 - 26718882
AN - SCOPUS:84958985631
SN - 1556-0864
VL - 11
SP - 261
EP - 265
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 2
ER -